NEUROS MEDICAL, INC.

Profile

Company Names

NEUROS MEDICAL, INC.

Addresses

26800 ALISO VIEJO PKWY, SUITE 250, ALISO VIEJO, CA 92656

26800 ALISO VIEJO PARKWAY, SUITE 250, ALISO VIEJO, CA 92656

35010 CHARDON ROAD, SUITE 210, WILLOUGHBY HILLS, OH 44094

4230 CHILLICOTHE ROAD (ROUTE 306), SUITE 105, WILLOUGHBY, OH 44094

11000 CEDAR AVENUE, SUITE 100, CLEVELAND, OH 44106

Phone Numbers

440-951-2565
216-658-3989

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER TECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$153,974,469.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2025-07-09 
$55,999,997.00 
$64,999,994.00 
$8,999,997.00 
Equity 
10
2023-06-16 
$20,000,000.00 
$20,000,431.00 
$431.00 
Equity 
9
2022-11-15 
$8,229,699.00 
$10,000,000.00 
$1,770,301.00 
Debt 
8
2020-10-27 
$36,981,418.00 
$42,777,148.00 
$5,795,730.00 
Equity 
7
2020-05-27 
$2,200,000.00 
$5,500,000.00 
$3,300,000.00 
Debt 
6
2019-10-11 
$2,385,759.00 
$9,235,791.00 
$6,850,032.00 
Equity 
5
2017-08-03 
$22,634,257.00 
$22,659,257.00 
$25,000.00 
Equity 
4
2017-08-02 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2013-01-22 
$1,750,000.00 
$1,750,000.00 
$0.00 
Debt 
2
2011-11-22 
$2,508,310.00 
$4,000,000.00 
$1,491,690.00 
Equity 
1
2009-08-20 
$1,285,029.00 
$1,800,000.00 
$514,971.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RANDY 
 
BAN 
DIRECTOR
SCOTT 
F. 
DREES 
DIRECTOR
STEPHEN 
R. 
HAYNES 
DIRECTOR
JOSEPH 
J. 
JANKOWSKI 
DIRECTOR
JOSEPH 
JOHN 
JANKOWSKI 
DIRECTOR
ALAN 
 
KAGANOV 
DIRECTOR
CLAIBORNE 
R. 
RANKIN 
DIRECTOR
CLAIBORNE 
READ 
RANKIN 
DIRECTOR
JON 
J. 
SNYDER 
EXECUTIVE OFFICER, DIRECTOR
JON 
JOSEPH 
SNYDER 
EXECUTIVE OFFICER, DIRECTOR
ZACH 
 
STASSEN 
EXECUTIVE OFFICER
MARK 
W. 
TEAGUE 
EXECUTIVE OFFICER
DAVID 
 
VEINO 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
C. 
WILDER 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-11-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-01-22 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-22 
D
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2009-08-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#